Clorox (NYS: CLX) reported earnings on Feb. 4. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q2), Clorox beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue grew and GAAP earnings per share expanded significantly.
Margins grew across the board.
Clorox reported revenue of $1.33 billion. The 12 analysts polled by S&P Capital IQ foresaw a top line of $1.27 billion on the same basis. GAAP reported sales were 8.5% higher than the prior-year quarter's $1.22 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.93. The 17 earnings estimates compiled by S&P Capital IQ forecast $0.80 per share. GAAP EPS of $0.93 for Q2 were 18% higher than the prior-year quarter's $0.79 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 42.5%, 100 basis points better than the prior-year quarter. Operating margin was 16.0%, 130 basis points better than the prior-year quarter. Net margin was 9.3%, 70 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $1.43 billion. On the bottom line, the average EPS estimate is $1.10.
Next year's average estimate for revenue is $5.63 billion. The average EPS estimate is $4.32.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 837 members out of 874 rating the stock outperform, and 37 members rating it underperform. Among 307 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 304 give Clorox a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Clorox is hold, with an average price target of $75.57.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Clorox. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
Add Clorox to My Watchlist.
The article Clorox Beats on Both Top and Bottom Lines originally appeared on Fool.com.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.